IRIS
LETTINI, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 771
EU - Europa 707
AS - Asia 318
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
Totale 1.804
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 768
IE - Irlanda 266
CN - Cina 224
UA - Ucraina 149
SE - Svezia 131
SG - Singapore 52
DE - Germania 44
IT - Italia 40
FR - Francia 28
FI - Finlandia 19
HK - Hong Kong 18
TR - Turchia 15
GB - Regno Unito 10
BE - Belgio 9
NL - Olanda 5
CZ - Repubblica Ceca 4
CA - Canada 3
EU - Europa 3
BR - Brasile 2
CL - Cile 2
IN - India 2
JP - Giappone 2
A2 - ???statistics.table.value.countryCode.A2??? 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
IR - Iran 1
JO - Giordania 1
LT - Lituania 1
Totale 1.804
Salva come PNG Salva come JPEG
Città #
Dublin 266
Chandler 172
Jacksonville 109
Nyköping 104
Dearborn 80
New York 58
Nanjing 47
Singapore 43
Munich 34
Princeton 28
Santa Clara 28
Ashburn 26
Beijing 24
Wilmington 21
Nanchang 20
Hong Kong 18
Jinan 15
Helsinki 13
Shenyang 13
Tianjin 11
Ann Arbor 10
Hebei 10
Kunming 10
Los Angeles 10
San Mateo 10
Brussels 9
Changsha 9
Jiaxing 9
Des Moines 6
Foggia 6
Guangzhou 6
Hangzhou 6
London 6
Zhengzhou 5
Brno 4
Ningbo 4
Boardman 3
Lanzhou 3
Norwalk 3
Orange 3
Seattle 3
Bari 2
Changchun 2
Chicago 2
Chongqing 2
Ferrandina 2
Frankfurt am Main 2
Fuzhou 2
Istanbul 2
Shanghai 2
Taizhou 2
Toronto 2
Washington 2
Woodbridge 2
Amityville 1
Amman 1
Ardabil 1
Augusta 1
Avigliano 1
Basra 1
Belo Horizonte 1
Berlin 1
Boston 1
Ferrara 1
Forest City 1
Fuyang 1
Hefei 1
Illange 1
Jakarta 1
Kashiwa 1
La Canada Flintridge 1
Nocera Terinese 1
Ottawa 1
Paris 1
Portland 1
Redwood City 1
Rockville 1
Rome 1
Rovereto 1
Shaoxing 1
Shenzhen 1
Stevenage 1
São Paulo 1
Taiyuan 1
Tampa 1
Tel Aviv 1
Weihai 1
Wuhan 1
Xingtai 1
Yiwu 1
Zibo 1
Totale 1.328
Salva come PNG Salva come JPEG
Nome #
TRAP1 favor glycolytic metabolism and resistance to EGFR inhibitors in human colorectal carcinoma through regulation of PFK. 96
TRAP1 protein signature predicts outcome in human metastatic colorectal carcinoma 90
COMPARATIVE GENE EXPRESSION PROFILING OF TOBACCO-ASSOCIATED HPV-POSITIVE VERSUS NEGATIVE ORAL SQUAMOUS CARCINOMA CELL LINES. 86
Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma 82
TRAP1 controls cell cycle G2-M transition through the regulation of CDK1 and MAD2 expression/ubiquitination 82
TRAP1 controls cell cycle G2–M transition through the regulation of CDK1 and MAD2 expression/ubiquitination 81
TRAP1 controls cell cycle progression through the regulation of CDK1 and MAD2 expression/ubiquitination in human breast, colon and lung carcinomas. 81
CDKN2A deletion in peritoneal mesotheliomas is correlated with loss of p16 protein expression and poor survival 78
Evaluation of Glucose Uptake in Normal and Cancer Cell Lines by Positron Emission Tomography 78
TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma 78
TRAP1 favors glycolytic metabolism and resistance to EGFR inhibitors in human colorectal carcinoma through regulation of PFK. 75
The reciprocal regulation between TRAP1 and BRAF is responsible for control of cell cycle progression and modulation of mitochondrial apoptotic pathway. 75
TRAP1 downregulation in human ovarian cancer enhances invasion and Epithelial-Mesenchymal Transition 73
TRAP1 is a novel molecular target in BRAF-driven human colorectal carcinomas 72
RAD6: A new target to overcome platinum resistance in ovarian cancer? 69
TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas. 67
New TRAP1 and Hsp90 chaperone inhibitors with cationic components: preliminary studies on mitochondrial targeting 66
New TRAP1 and Hsp90 chaperone inhibitors with cationic components: Preliminary studies on mitochondrial targeting 66
TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas 65
TRAP1 represents a key mediator of stemness and glycolytic metabolism in colorectal cancer cells. 64
TRAP1: a viable therapeutic target for future cancer treatments? 58
New TRAP1 and HSP90 cheprone inhibitors with cationic components: preliminary studies on mitochondrial targeting 58
TRAP1 regulates stemness through Wnt/β-Catenin pathway in human colorectal carcinoma. 52
TRAP1 favors glycolytic metabolism and resistance to EGFR inhibitors in human colorectal carcinoma through regulation of PFK. 51
Comparative gene expression profiling of tobacco-associated HPV-positive versus negative oral squamous carcinoma cell lines 50
Heat shock proteins in cancer stem cell maintenance: A potential therapeutic target? 47
Heat shock proteins in thyroid malignancies: Potential therapeutic targets for poorly-differentiated and anaplastic tumours? 46
TRAP1 regulates Wnt/β-catenin pathway through LRP5/6 receptors expression modulation 23
Totale 1.909
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.190
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020126 0 0 0 0 0 0 47 9 27 6 29 8
2020/2021196 24 0 20 3 23 4 29 23 37 31 0 2
2021/2022126 9 0 4 0 12 1 3 14 14 12 1 56
2022/2023695 58 36 39 26 40 73 0 69 325 6 10 13
2023/2024142 21 6 6 3 7 64 5 8 0 2 0 20
2024/2025174 23 33 5 17 30 65 1 0 0 0 0 0
Totale 1.909